Comparison Overview
ALS Pharmaceutical Australia
ALS Pharmaceutical Australia
10/2-8 South Street, Rydalmere, Sydney, NSW, 2116, AU
Last Update: 17/11/2025
ALS Pharmaceutical Australia provides laboratory testing services to the Pharmaceutical, Veterinary & Cosmetic industries.
Hikma Pharmaceuticals
1 New Burlington Place, London, W1S 2HR, GB
Last Update: 03/04/2026
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...
Compliance Ranges Comparison
ALS Pharmaceutical Australia
Hikma Pharmaceuticals
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for ALS Pharmaceutical Australia in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Hikma Pharmaceuticals in 2026.
Incident History - ALS Pharmaceutical Australia (X = Date, Y = Severity)
ALS Pharmaceutical Australia cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)
Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
ALS Pharmaceutical Australia
Hikma Pharmaceuticals
FAQ
Latest Global CVEs
Improper access control in Microsoft Edge for Android allows an unauthorized attacker to bypass a security feature over a network.
A security vulnerability has been detected in NousResearch hermes-agent up to 2026.4.30. Affected is the function GatewayStreamConsumer._filter_and_accumulate of the file gateway/stream_consumer.py of the component Streaming Reasoning Tag Filter. The manipulation leads to improper handling of case sensitivity. The attack may be initiated remotely. The attack's complexity is rated as high. The exploitability is told to be difficult. The exploit has been disclosed publicly and may be used. The project decided to not implement a dedicated fix: "[T]he analysis and the fix are both sound. It just lands below the bar for the maintenance cost of a duplicated scrub path."
- https://gist.github.com/YLChen-007/2229e5505bcbb3e15a7ae8fba4c4be37
- https://github.com/NousResearch/hermes-agent/
- https://github.com/NousResearch/hermes-agent/issues/27288
- https://github.com/NousResearch/hermes-agent/pull/28631#issuecomment-4622188016
- https://vuldb.com/cve/CVE-2026-14617
- https://vuldb.com/submit/844654
- https://vuldb.com/vuln/376134
- https://vuldb.com/vuln/376134/cti
Insufficient ui warning of dangerous operations in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.
Improper neutralization of input during web page generation ('cross-site scripting') in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.
Relative path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.